C1q nephropathy: A variant of focal segmental glomerulosclerosis

Slides:



Advertisements
Similar presentations
Schematic diagram of a lobe of a normal glomerulus.
Advertisements

Volume 54, Issue 2, Pages (August 1998)
Myeloma-related Kidney Disease
Volume 65, Issue 5, Pages (May 2004)
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)
Paraneoplastic glomerulopathies: New insights into an old entity
Volume 65, Issue 2, Pages (February 2004)
Vivette D D'Agati, MD, Agnes B Fogo, MD, Jan A Bruijn, MD, J
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Chronic lymphocytic leukemia and cryoglobulinemic glomerulonephritis
Glomerular Diseases Associated With Cancer, Chemotherapy, and Hematopoietic Stem Cell Transplantation  Kenar D. Jhaveri, Hitesh H. Shah, Chinmay Patel,
Behzad Najafian, MD, Mark A. Lusco, MD, Laura S. Finn, MD, Charles E
Volume 56, Issue 5, Pages (November 1999)
Volume 76, Issue 5, Pages (September 2009)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Infantile nephropathic cystinosis
Glomerular disease related to anti-VEGF therapy
Sickle Cell Nephropathy
Volume 59, Issue 1, Pages (January 2001)
Volume 64, Issue 1, Pages (July 2003)
Volume 78, Issue 11, Pages (December 2010)
Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 62, Issue 1, Pages (July 2002)
The spectrum of kidney biopsy findings in patients with morbid obesity
Postinfectious Glomerulonephritis
Lupus Nephritis: Proliferative Forms (WHO III, IV)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 59, Issue 6, Pages (June 2001)
Toward a working definition of C3 glomerulopathy by immunofluorescence
Uromodulin storage disease
M.B. Stokes, A.M. Valeri, G.S. Markowitz, V.D. D'Agati 
Volume 88, Issue 4, Pages (October 2015)
Volume 65, Issue 2, Pages (February 2004)
Volume 79, Issue 6, Pages (March 2011)
S.H. Nasr, D.C. Preddie, G.S. Markowitz, G.B. Appel, V.D. D'Agati 
Volume 86, Issue 6, Pages (December 2014)
Volume 68, Issue 4, Pages (October 2005)
Obesity-related glomerulopathy: An emerging epidemic
HIV-related nephropathy: A South African perspective
Volume 63, Issue 4, Pages (April 2003)
Hypertension, race, and glomeruli: more than simply a numbers game
Volume 65, Issue 1, Pages (January 2004)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Primary renal allograft dysfunction
Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases  Mazdak A. Khalighi, Alexander J. Gallan, Anthony Chang, Shane M. Meehan 
C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
AJKD Atlas of Renal Pathology: Minimal Change Disease
Myeloproliferative neoplasms cause glomerulopathy
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis
AIDS, nephrotic-range proteinuria, and renal failure
Light Chain Deposition Disease
Volume 57, Issue 5, Pages (May 2000)
C1q Nephropathy American Journal of Kidney Diseases
IgA Nephropathy American Journal of Kidney Diseases
Volume 70, Issue 2, Pages (July 2006)
Kirk J. Maurer, Robert P. Marini, James G. Fox, Arlin B. Rogers 
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 73, Issue 5, Pages (March 2008)
Agnes B. Fogo, MD, Mark A. Lusco, MD, Behzad Najafian, MD, Charles E
Clinical and Pathological Characterization of Mesoamerican Nephropathy: A New Kidney Disease in Central America  Julia Wijkström, MD, Ricardo Leiva, MD,
Volume 63, Issue 6, Pages (June 2003)
Quiz Page Answers May 2006 American Journal of Kidney Diseases
M.B. Stokes, B. Aronoff, D. Siegel, V.D. D'Agati  Kidney International 
Bisphosphonate nephrotoxicity
Volume 1, Issue 3, Pages (May 2019)
Collapsing glomerulopathy (CG) and lesions that may resemble CG histologically in renal biopsies from patients with systemic lupus erythematosus. Collapsing.
A glomerulus exhibits global wrinkling and retraction of the glomerular basement membrane and diffuse swelling and hyperplasia of overlying visceral epithelial.
IgA Nephropathy American Journal of Kidney Diseases
Presentation transcript:

C1q nephropathy: A variant of focal segmental glomerulosclerosis Glen S. Markowitz, Joshua A. Schwimmer, M. Barry Stokes, Samih Nasr, Robert L. Seigle, Anthony M. Valeri, Vivette D. D'Agati  Kidney International  Volume 64, Issue 4, Pages 1232-1240 (October 2003) DOI: 10.1046/j.1523-1755.2003.00218.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Pathologic findings in C1q nephropathy. (A) Low power view shows focal and segmental glomerulosclerosis affecting two of three glomeruli. The uninvolved glomerulus appears unremarkable. There is patchy tubular atrophy and interstitial fibrosis associated with mild chronic interstitial inflammation [Periodic acid-Schiff (PAS), ×100]. (B) A representative glomerulus displays focal segmental glomerulosclerosis (FSGS) not otherwise specified with a discrete lesion of segmental sclerosis affecting half of the tuft. There is capping of the overlying podocytes (PAS, ×400). (C) A glomerulus shows a collapsing lesion of sclerosis with segmental obliteration of the capillary lumina by wrinkling of the glomerular basement membrane. There is marked hypertrophy and hyperplasia of the podocytes, many of which contain PAS positive protein resorption droplets (PAS, ×250). (D) This glomerulus displays a cellular lesion of segmental sclerosis with expansion of the capillary lumen by endocapillary foam cells. The adjacent segments of the glomerulus have mild mesangial hypercellularity [hematoxylin and eosin (H&E), ×400]. (E) An example of C1q nephropathy with mild global mesangial hypercellularity. Other glomeruli (not illustrated) from this biopsy displayed FSGS (H&E, ×400). (F) On high power examination, fuchsinophilic deposits that expand the mesangium can be identified with the trichrome stain (see arrows) (×630). (G) Immunofluorescence staining for C1q shows global, high-intensity positivity outlining the mesangial areas, with a comma-like appearance (×400). (H) Electron micrograph shows a mesangial electron-dense deposit beneath the glomerular basement membrane reflection over the mesangium (an area often referred to as “paramesangial”). No electron dense deposits are seen involving the peripheral glomerular capillary walls. There is mild foot process effacement (×2000). Kidney International 2003 64, 1232-1240DOI: (10.1046/j.1523-1755.2003.00218.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Immunofluorescence findings in C1q nephropathy. This double-bar graph depicts the prevalence (left axis) and mean intensity (right axis) of immunofluorescence staining in all 19 cases of C1q nephropathy. The corresponding numerical values are provided in Table 3. Kidney International 2003 64, 1232-1240DOI: (10.1046/j.1523-1755.2003.00218.x) Copyright © 2003 International Society of Nephrology Terms and Conditions